Quantcast

Industry news that matters to you.  Learn more

Cancer Biomarker Study Data Presented at the 2011 AACR Meeting

A roundup of five research studies on cancer biomarkers that were presented earlier this week at the American Association for Cancer Research (AACR) 102nd Annual Meeting in Orlando, Florida.

Quest Diagnostics to Acquire Celera

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic testing, information and services, and Celera Corporation, one of the world’s pioneers in genetic diagnostics discovery and development, announced last week that they have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera for $8 per share, representing a transaction value of approximately $344 million, net of $327 million in acquired cash and short-term investments.